Immunotherapy wipes out some colorectal tumors without surgery, signaling a major shift toward less invasive treatment.

In a recent study, Stevens researchers have shown how colorectal cancers can evolve from mature intestinal cells that revert ...

Analysis of 35,213 patients with stage II-III colon cancer revealed that recurrence risk drops below 0.5% at 6 years post-surgery, supporting a practical definition of cure. Women showed a ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...

Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer screening has helped ...

The ATOMIC Trial shows how adding immunotherapy to chemotherapy may reduce recurrence risk and improve outcomes in stage III dMMR colon cancer. To better understand the role of immunotherapy in colon ...

Colorectal cancer is a complex disease. Understanding its fundamental aspects can empower you to have more informed and productive conversations with your oncologist. Colorectal cancer (CRC) is a ...

Colon cancer symptoms in women are similar to those in men, but they can be confused with gynecological issues, like cramping ...